• Home
  • >
  • Vivanza Biosciences Ltd Financials
https://storage.googleapis.com/assets.cdp.blinkx.in/Blinkx_Website/icons/vivanza-biosciences-ltd.png Logo

Vivanza Biosciences Ltd Financial Statement

Vivanza Biosciences Ltd Income Statement
Quarterly
Annual

*All values are in Rs. Cr

(Rs. CR)Mar 2024Dec 2023Sep 2023
Revenue2.273.383.92
Operating Expense2.433.13.63
Net Profit-0.380.180.19
Net Profit Margin-16.745.334.85
Earning Per Share-0.090.050.05
EBIDTA-0.170.280.3
Effective Tax Rate-68.75TBATBA

(Rs. Cr)

Revenue

Operating Expense

Net Profit

Net Profit Margin

Earning Per Share

EBIDTA

Effective Tax Rate

Vivanza Biosciences Ltd Profit & Loss

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Total Revenue Annual17.8110.49.89
Operating Expenses Annual17.1410.489.79
Operating Profit Annual1.140.750.6
Interest Annual0.420.410.47
Depreciation00.010.01
Net Profit Annual0.60.330.08
Tax Annual0.1200.05

Particulars

Total Revenue Annual

Operating Expenses Annual

Operating Profit Annual

Interest Annual

Depreciation

Net Profit Annual

Tax Annual

Vivanza Biosciences Ltd Cash Flow

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Cash Flow at the Beginning0.060.07-2.81
Cash Flow from Operations-0.952.47-3.08
Cash Flow from InvestingTBATBA-0.02
Cash Flow from Financing1.03-2.482.8
Cash Flow at the End0.140.06-3.11

Particulars

Cash Flow at the Beginning

Cash Flow from Operations

Cash Flow from Investing

Cash Flow from Financing

Cash Flow at the End

Vivanza Biosciences Ltd Key Ratios

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
PBDIT Margin (%)6.467.46.07
PBIT Margin (%)6.467.315.97
PBT Margin (%)-12.33-12.03-7.91
Net PROFIT Margin (%)4.015.031.08
Return On Networth / Equity (%)14.848.252.26
Return On Networth /Employed(%)10.6510.9615.32
Return On Assets (%)6.788.353.07
Total Debt / Equity(X)1.330.640.05
Asset Turnover Ratio (%)1.691.662.83

Particulars

PBDIT Margin (%)

PBIT Margin (%)

PBT Margin (%)

Net PROFIT Margin (%)

Return On Networth / Equity (%)

Return On Networth / Employed(%)

Return On Assets (%)

Total Debt / Equity(X)

Asset Turnover Ratio (%)

Vivanza Biosciences Ltd Balance Sheet

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Fixed Assets Annual2.312.322.32
Total Current Assets Annual19.5512.455.01
Non Current Assets Annual2.923.113.43
Total Shareholders Funds Annual4.093.493.16
Total Assets Annual22.4815.568.45

Particulars

Fixed Assets Annual

Total Current Assets Annual

Non Current Assets Annual

Total Shareholders Funds Annual

Total Assets Annual

Vivanza Biosciences Ltd Earning Calls
Mar 2024
EPS beaten by 0.00 %

Open Demat Account

50years
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O

Dividend Pages

PE Ratio

Get Your FAQs Right

As of May 20, 2024, Vivanza Biosciences Ltd has a market capitalization of 27.16 Cr. Value Research classifies it as a Micro-Cap company.

No, Vivanza Biosciences Ltd is not debt-free with a debt-to-equity ratio of 1.11.

In FY 2023, Vivanza Biosciences Ltd recorded a total revenue of approximately 27.84 Cr marking a significant milestone in the company's financial performance.

Vivanza Biosciences Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.5% and 0.5% annually, respectively..

Vivanza Biosciences Ltd's current PE ratio is 49.38.

Vivanza Biosciences Ltd's ROCE averaged 10.8% from the FY ending March 2022 to 2024, with a median of 11.3%. It peaked at 11.8% in March 2022, reflecting strong capital efficiency over the period..

Vivanza Biosciences Ltd's latest EBIT is Rs. 1.11 Cr, surpassing the average EBIT of Rs. 1 Cr over the 5 years..